Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowThis statistic shows the net income of Fresenius SE in 2022 and 2023, by segment. In 2023, the German medical technology company spent over 604 million euros in R&D spending in its Fresenius Kabi segment.
You only have access to basic statistics.
Business Solutions including all features.
Market position
Key facts
Business distribution
Competitors
Further related statistics